OptimizeRx Corporation
OPRX
$15.27
-$0.11-0.72%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.00K | -9.87M | -15.41M | -20.11M | -24.17M |
| Total Depreciation and Amortization | 4.57M | 4.57M | 4.57M | 4.57M | 4.25M |
| Total Amortization of Deferred Charges | 1.08M | 1.10M | 847.00K | 835.00K | 848.00K |
| Total Other Non-Cash Items | 9.40M | 17.54M | 18.95M | 20.55M | 27.75M |
| Change in Net Operating Assets | -3.27M | -2.93M | -2.33M | -954.00K | -10.24M |
| Cash from Operations | 11.83M | 10.41M | 6.64M | 4.89M | -1.57M |
| Capital Expenditure | -64.00K | -72.00K | -107.00K | -112.00K | -100.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | 10.00K |
| Cash Acquisitions | -- | -- | -- | -- | -82.95M |
| Divestitures | -- | -- | -- | -- | 2.54M |
| Other Investing Activities | -194.00K | -268.00K | -274.00K | -338.00K | 54.17M |
| Cash from Investing | -258.00K | -340.00K | -381.00K | -450.00K | -26.33M |
| Total Debt Issued | -- | -- | -- | -- | 37.73M |
| Total Debt Repaid | -8.00M | -8.00M | -4.00M | -4.00M | -3.21M |
| Issuance of Common Stock | 338.00K | -- | -- | -- | 15.00K |
| Repurchase of Common Stock | -512.00K | -448.00K | -858.00K | -911.00K | -733.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 300.00K |
| Cash from Financing | -8.17M | -8.45M | -4.86M | -4.91M | 34.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -1.00K |
| Net Change in Cash | 3.39M | 1.63M | 1.40M | -472.00K | 6.20M |